Ratnakar Securities Pvt. Ltd.

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC

BSE8278.10143.1 (+1.76 %)

PREV CLOSE ( ) 8135.00

OPEN PRICE ( ) 8279.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 425

TODAY'S LOW / HIGH ( )8183.90 8295.95

52 WK LOW / HIGH ( )5329.7 9370.35

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-05 1956

Management Info

Aditya Narayan - Chairman Rodolfo Hrosz - Managing Director

Registered Office

Address Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone 022-2803 2000

Email igrc.sil@sanofi.com

Website www.sanofiindialtd.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE, MCX

NEWS

27Mar Sanofi India enters into partnership w
Sanofi India (SIL) and Sanofi Healthcare India (together referred as â€˜..

27Mar Sanofi India shines on entering into p
Sanofi India is currently trading at Rs. 8049.00, up by 338.15 points or..

12Mar Sanofi India informs about loss of sha
Sanofi India has informed that the Company has received communication fr..

11Mar Sanofi India informs about loss of sha
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosur..

26Feb Sanofi India informs about outcome of
Sanofi India has informed that it enclosed the presentation made to the..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	1377	6032
Gross Profit	1888	8458
Operating Profit	1994	8693
Net Sales	6939	28511

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE) 4025.35 (4.81%)	M.Cap ( in Cr)106860.39
Abbott India (BSE) 25864.85 (0.54%)	M.Cap ( in Cr)54961.00
Astrazeneca Pharma I (BSE) 5415.40 (2.18%)	M.Cap ( in Cr)13538.50
Glaxosmithkline Phar (BSE) 2132.75 (3.26%)	M.Cap ( in Cr)36130.07
Ajanta Pharma (BSE) 2200.70 (2.94%)	M.Cap ( in Cr)27710.26

Shareholding Pattern

	PROMOTERS	60.4%
	MUTUAL FUNDS/UTI	11.67%
	FI/BANKS/INSURANCE	11.17%
	NON-INSTITUTION	10.61%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bajaj Finserv Flexi...	3.18
Nippon India Pharma...	2.69
Aditya Birla SL Pha...	2.66
DSP Nifty Smallcap2...	2.57
LIC MF Dividend Yie...	2.12
PGIM India Small Ca...	2.10

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

SANOFI INDIA LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES